| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |
,||,¶
,
,¶
,§,¶
,
,¶
*
Channing Laboratory, Department of Medicine, Brigham and Womens'
Hospital
Department of Nutrition, Harvard School of Public Health Boston,
Massachusetts.
Department of Epidemiology Harvard School of Public Health Boston,
Massachusetts.
§
Department of Environmental Health, Harvard School of Public Health
Boston, Massachusetts.
||
Renal Unit, Department of Medicine, Massachusetts General Hospital Boston,
Massachusetts.
¶
Harvard Medical School, Boston, Massachusetts.
Correspondence to Dr. Gary C. Curhan, Channing Laboratory, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-525-2683; Fax: 617-525-2008; E-mail: gary.curhan{at}channing.harvard.edu
Abstract. Urinary oxalate is an important determinant of calcium
oxalate kidney stone formation. High doses of vitamin B6 may decrease oxalate
production, whereas vitamin C can be metabolized to oxalate. This study was
conducted to examine the association between the intakes of vitamins B6 and C
and risk of kidney stone formation in women. The relation between the intake
of vitamins B6 and C and the risk of symptomatic kidney stones were
prospectively studied in a cohort of 85,557 women with no history of kidney
stones. Semiquantitative food-frequency questionnaires were used to assess
vitamin consumption from both foods and supplements. A total of 1078 incident
cases of kidney stones was documented during the 14-yr follow-up period. A
high intake of vitamin B6 was inversely associated with risk of stone
formation. After adjusting for other dietary factors, the relative risk of
incident stone formation for women in the highest category of B6 intake
(
40 mg/d) compared with the lowest category (<3 mg/d) was 0.66 (95%
confidence interval, 0.44 to 0.98). In contrast, vitamin C intake was not
associated with risk. The multivariate relative risk for women in the highest
category of vitamin C intake (
1500 mg/d) compared with the lowest category
(<250 mg/d) was 1.06 (95% confidence interval, 0.69 to 1.64). Large doses
of vitamin B6 may reduce the risk of kidney stone formation in women. Routine
restriction of vitamin C to prevent stone formation appears unwarranted.
This article has been cited by other articles:
![]() |
J. N Hathcock, B. Frei, S. Lawson, and C. Johnston Reply to L Massey Am. J. Clinical Nutrition, August 1, 2005; 82(2): 489 - 489. [Full Text] [PDF] |
||||
![]() |
L. K. Massey, M. Liebman, and S. A. Kynast-Gales Ascorbate Increases Human Oxaluria and Kidney Stone Risk J. Nutr., July 1, 2005; 135(7): 1673 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Reynolds Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis J. Clin. Pathol., February 1, 2005; 58(2): 134 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Coburn, R. D Reynolds, J D. Mahuren, W. E Schaltenbrand, Y. Wang, K. L Ericson, M. P Whyte, Y. M Zubovic, P. J Ziegler, D. L Costill, et al. Elevated plasma 4-pyridoxic acid in renal insufficiency Am. J. Clinical Nutrition, January 1, 2002; 75(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Heilberg Update on dietary recommendations and medical treatment of renal stone disease Nephrol. Dial. Transplant., January 1, 2000; 15(1): 117 - 123. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673